The effect of the expression of angiotensin II on extracellular matrix metalloproteinase inducer (EMMPRIN) in macrophages is mediated via the AT1/COX-2/PGE2 pathway

被引:15
作者
Yang, Li-xia [1 ]
Ye, Jin-shan [1 ]
Guo, Rui-wei [1 ]
Liu, Hong [1 ]
Wang, Xian-mei [1 ]
Qi, Feng [1 ]
Guo, Chuanming [1 ]
机构
[1] Kunming Gen Hosp Chengdu Mil Area, Dept Cardiol, Yunnan 650032, Peoples R China
关键词
Angiotensin II; Macrophage; Extracellular matrix metalloproteinase inducer; Losartan; PGE(2); ATHEROSCLEROTIC LESION FORMATION; SMOOTH-MUSCLE-CELLS; E-DEFICIENT MICE; CARDIOVASCULAR EVENTS; PLAQUE INSTABILITY; CANCER-CELLS; CYCLOOXYGENASE-2; INHIBITION; DISEASE; TRIAL;
D O I
10.1007/s00011-010-0223-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To explore the expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in THP-1 macrophages induced by angiotensin II (Ang II) and the mechanism of EMMPRIN expression. THP-1 cells were cultured and induced into macrophages, then stimulated with 10(-6) mol/L Ang II. Levels of EMMPRIN gene and its protein were measured by real-time polymerase chain reaction and western blotting. Prostaglandin E-2 (PGE(2)) expression was assayed by enzyme-linked immunosorbent assay. Antagonists of the angiotensin type-1 receptor (AT(1)R) and angiotensin type-2 receptor (AT(2)R) were used to inhibit the effect of Ang II, and PGE(2) added to detail the mechanism of Ang II-induced EMMPRIN expression. Ang II clearly induced the expression of EMMPRIN mRNA and protein in macrophages; this expression peaked at 12 h and declined after 24 h. The tendency of enhancement of the levels of cyclooxygenase-2 (COX-2) and PGE(2) was coincident with EMMPRIN expression. AT(1)-receptor antagonists and COX-2 inhibitors inhibited the effect of Ang II, but AT(2)-receptor antagonists did not. Ang II can up-regulate EMMPRIN expression in THP-1 macrophages via the AT(1)/COX-2/PGE(2) signal transduction pathway, and the effect can be inhibited by losartan and NS-398.
引用
收藏
页码:1033 / 1040
页数:8
相关论文
共 41 条
  • [1] C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages: Inhibitory effect of fluvastatin
    Abe, N
    Osanai, T
    Fujiwara, T
    Kameda, K
    Matsunaga, T
    Okumura, K
    [J]. LIFE SCIENCES, 2006, 78 (09) : 1021 - 1028
  • [2] Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice
    Ayabe, N
    Babaev, VR
    Tang, YW
    Tanizawa, T
    Fogo, AB
    Linton, MF
    Ichikawaa, I
    Fazio, S
    Kon, V
    [J]. ATHEROSCLEROSIS, 2006, 184 (02) : 312 - 321
  • [3] BISWAS C, 1995, CANCER RES, V55, P434
  • [4] Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice
    Blessing, Erwin
    Preusch, Michael
    Kranzhoefer, Roger
    Kinscherf, Ralf
    Marx, Nikolaus
    Rosenfeld, Michael E.
    Isermann, Berend
    Weber, Christian M.
    Kreuzer, Joerg
    Graefe, Julia
    Katus, Hugo A.
    Bea, Florian
    [J]. ATHEROSCLEROSIS, 2008, 199 (02) : 295 - 303
  • [5] ROLE OF ANGIOTENSIN-II AND PROSTAGLANDIN E(2) IN REGULATING CARDIAC FIBROBLAST COLLAGEN TURNOVER
    BRILLA, CG
    ZHOU, GP
    RUPP, H
    MAISCH, B
    WEBER, KT
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (13) : D8 - D13
  • [6] Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial
    Brown, DL
    Desai, KK
    Vakili, BA
    Nouneh, C
    Lee, HM
    Golub, LM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (04) : 733 - 738
  • [7] Cyclooxygenase-2 promotes early atherosclerotic lesion formation in apoE-deficient and C57BL/6 mice
    Burleigh, ME
    Babaev, VR
    Yancey, PG
    Major, AS
    McCaleb, JL
    Oates, JA
    Marrow, JD
    Fazio, S
    Linton, MF
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 39 (03) : 443 - 452
  • [8] Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice
    Burleigh, ME
    Babaev, VR
    Oates, JA
    Harris, RC
    Gautam, S
    Riendeau, D
    Marnett, LJ
    Morrow, JD
    Fazio, S
    Linton, MF
    [J]. CIRCULATION, 2002, 105 (15) : 1816 - 1823
  • [9] Novel determinants of plaque instability
    Cipollone, F
    Fazia, M
    Mezzetti, A
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (09) : 1962 - 1975
  • [10] Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity
    Cipollone, F
    Fazia, M
    Iezzi, A
    Pini, B
    Cuccurullo, C
    Zucchelli, M
    de Cesare, D
    Ucchino, S
    Spigonardo, F
    De Luca, M
    Muraro, R
    Bei, R
    Bucci, M
    Cuccurullo, F
    Mezzetti, A
    [J]. CIRCULATION, 2004, 109 (12) : 1482 - 1488